Clinical Impact and Relevance of Antiganglioside Antibodies Test Results / Antigangliozīdu Antivielu Testa Rezultātu Klīniskā Ietekme un Nozīme Pacientam

Bourque, P. R., Chardona, J..W., Massie, R. (2015). Autoimmune peripheral neuropathies, Clin., Chim., Acta, DOI: 10.1016/j.cca.2015.02.039.10.1016/j.cca.2015.02.03925748038Search in Google Scholar

Hughes, R. A., Cornblath, D. R. (2005). Guillain-Barré syndrome. Lancet, 366 (9497), 1653-1666.Search in Google Scholar

Kaida, K. (2013). Pathogenic roles of antiganglioside antibodies in immune- mediated neuropathies, Clin. Exp. Neuroimmunol., 4 (1), 60-69.10.1111/cen3.12007Search in Google Scholar

Kusunoki, S., Kaida, K., Ueda, M. (2008). Antibodies against gangliosides and ganglioside complexes in Guillain-Barré syndrome: New aspects of research. Biochim. Biophys. Acta, 1780, 441-44410.1016/j.bbagen.2007.10.00117976386Search in Google Scholar

Logina, I., Ķēniņa, V., Kurjāne, N., Gudreniece, A., Noviks, I. (2014). Autoimūno nervu sistēmas slimību klīniskās vadlīnijas [Clinical guidelines for neurologic autoimmune diseases]. Latvijas Neiroimunologu asociācija. Rīga. 81 lpp. (in Latvian).Search in Google Scholar

Rojas-Garcia, R., Querol, L., Gallardo, E., De Luna Salva, N., Juarez, C., Garces, M., Fages, E., Casasnovas, C., Illa, I. (2012). Clinical and serological features of acute sensory ataxic neuropathy with antiganglioside antibodies. J. Periph. Nerv. Syst., 17, 158-168.10.1111/j.1529-8027.2012.00407.x22734901Search in Google Scholar

Sejvar, J. J., Baughman, A. L., Wise, M., Morgan, O. W. (2011). Population incidence of Guillain-Barré Syndrome: A systematic review and metaanalysis. Neuroepidemiology, 36, 123-133.10.1159/000324710570304621422765Search in Google Scholar

Simons, K., Ehehalt, R. (2002). Cholesterol, lipid rafts, and disease. J. Clin. Invest., 110, 597-603.10.1172/JCI0216390Search in Google Scholar

Tatsumoto, M., Koga, M., Gilbert, M., Odaka, M., Hirata, K., Kuwabara, S., Yuki, N. (2006). Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a. J. Neuroimmunol., 177 (1-2), 201-208.10.1016/j.jneuroim.2006.04.00516844234Search in Google Scholar

Vernino, S., Wolfe, G. I. (2007). Antibody testing in peripheral neuropathies. Neurol. Clin., 25, 29-46.10.1016/j.ncl.2006.10.00217324719Search in Google Scholar

Yu, R. K., Usuki, S., Ariga, T. (2006), Ganglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseases. Infect Immun., 74 (12), 6517-6527. 10.1128/IAI.00967-06169809216966405Search in Google Scholar